The US Food and Drug Administration said on Thursday it has banned more products from Indian drugmaker Ranbaxy Laboratories Limited from entering the United States due to manufacturing violations.......
Leading Indian pharmaceutical company Ranbaxy Laboratories Limited has offered to provide oseltamivir phosphate capsules (generic version of Tamiflu) to the United States healthcare system to meet......
The Canadian health and drug regulator Health Canada has asked Ranbaxy Pharmaceuticals Canada (RPCI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL) to withdraw its generic, 25......
Ranbaxy, one of the first Indian companies to set up a venture in China in 1993, is bullish in its operations, securing increased market share for its innovative medicines and also for sourcing......
The United States Food and Drug Administration on Tuesday banned the import of more than 30 generic drugs manufactured by Ranbaxy Laboratories Limited alleging that poor quality control at the......